2'-fluoro-2'-deoxyadenosine has been researched along with B-Cell Chronic Lymphocytic Leukemia in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hulkkonen, J; Hurme, M; Kivekäs, I; Vilpo, J; Vilpo, L | 1 |
1 other study(ies) available for 2'-fluoro-2'-deoxyadenosine and B-Cell Chronic Lymphocytic Leukemia
| Article | Year |
|---|---|
CD80 antigen expression as a predictor of ex vivo chemosensitivity in chronic lymphocytic leukemia.
Topics: Antineoplastic Agents; B7-1 Antigen; Deoxyadenosines; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Vidarabine | 2002 |